Skip to main content
TipRanks
Go Ultimate75% OFF

Allen Wolff Insider Profile

4 Followers

Allen Wolff, Former Director and CEO, Director at Eterna Therapeutics, holds 132.72K shares in Eterna Therapeutics (Ticker: ERNA).

Allen Wolff's Trading History

ERNA
Eterna Therapeutics
Mar 26, 2021Former Director and CEO, DirectorUninformative Sell26.55K$222.97K
ERNA
Insider Shares: 132.72K (4.46%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 26, 2021Uninformative Sell$26.55K9,944$2.67―
Mar 22, 2021Uninformative Sell$730.71207$3.53―
Feb 22, 2021Uninformative Sell$995.67207$4.81―
Jan 20, 2021Uninformative Sell$7.62K2,987$2.55―
Dec 21, 2020Uninformative Sell$368.90170$2.17―

You May Also Like

Allen Wolff insider profile FAQ

What is the percentage of profitable transactions made by Allen Wolff?
The percentage of profitable transactions made by Allen Wolff is 33%.
What is the average return per transaction made by Allen Wolff?
The average return per transaction made by Allen Wolff is -23.90%.
What stocks does Allen Wolff hold?
Allen Wolff holds: ERNA stocks.
What was Allen Wolff’s latest transaction?
Allen Wolff’s latest transaction was an Uninformative Sell of $26.55K.
What was Allen Wolff's most profitable transaction?
Allen Wolff’s most profitable transaction was an Informative Buy of ERNA stock on June 14, 2016. The return on the trade was 1.50%.
What is Allen Wolff's role in Eterna Therapeutics?
Allen Wolff's role in Eterna Therapeutics is Former Director and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.